The College is pleased to offer these 15 to 30 minute modules that will give you CME designed to fit your busy schedule. Continue to visit this page as NEW modules will be added as they are developed.
Asthma and Respiratory & Sleep Disorders
- NEW Is the Basophil Activation Test Ready for Primetime? (22m)
- NEW Addressing Unproven Diagnostic Testing (20m)
- NEW Pediatric Asthma (12m)
- NEW Immunology of Sleep (19m)
- NEW NIH Asthma Guidelines (28m)
- NEW Targeted Therapies for Specific Asthma Phenotypes (28m)
- NEW Economic Outlook for Biologics in Asthma - Are They Cost-Effective? (23m)
- NEW What Have We Gleaned from Our Experiences with Currently Approved Biologics? (22m)
- Biomarker Interpretations and How This Would Aid in Treatment Choice and Prognosis Prediction (25m)
- Kids Are Not Little Adults: Unique Aspects to Diagnosis and Treatment of Cough in Children (26m)
Dermatology
- NEW Generalized Dermatitis (10m)
- NEW What's New: Update in Pediatric Dermatology (18m)
- NEW Treatment Approaches for Difficult to Control Urticaria (12m)
- Emerging Therapies for Refractory Urticaria (23m)
- Dermatitis in Skin of Color (23m)
- Anaphylaxis (13m)
- Immunology (13m)
Environmental and Integrative Medicine
- NEW Climate Change, Allergic Disease (24m)
Immunotherapy & Diagnostics
- NEW "Rules" of OIT - Patient Illness, Vacations, Exercise, and More (19m)
- NEW More than Peanut - Expanding Your OIT Program to Include Other Foods (12m)
- NEW Allergens and Standardization (16m)
- NEW SLIT Basics for the Allergist (19m)
- Do Patients Receiving Subcutaneous Immunotherapy Need To Have an Epinephrine Auto-injector Prescribed? (33m)
- SCIT or SLIT: No One Option Is Perfect - A Role for Shared Decision-making (30m)
- Beyond OIT: How Biologics Can Help Patients With Food Allergy (24m)
- Navigating Current Asthma Choices (43m)
Practice Management & Professional Issues
Clinical Immunology & Autoimmune and Biologicals
Food and Drug Allergy & GI Disorders
- NEW Pediatric Food Allergy Treatment (11m)
- NEW The FPIES Patient - Diagnosis & Management Approaches (23m)
- NEW Hypersensitivity to beta-lactams and NSAIDs (21m)
- NEW Adverse Reactions to Biologics and Chemotherapy (21m)
- FDA-Approved Oral Immunotherapy (21m)
- Ongoing Avoidance Without Treatment (16m)
- Using Shared Decision-making to Guide Patients Through the Options (18m)
- FPIES - Prevalence, Diagnosis and Management Pearls (22m)
- Eosinophilic Esophagitis (33m)